From: Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer
Yes definitely | Probably | Possibly | Very unlikely | No | |
---|---|---|---|---|---|
Postmenopausal | 111(50.0) | 71 (32.0) | 28 (12.6) | 8 (3.6) | 4(1.8) |
Early menopause | 20 (9.4) | 34 (16.0) | 77 (36.3) | 54 (25.5) | 27 (12.7) |
History of endometriosis | 6 (2.8) | 11 (5.1) | 77 (35.5) | 86 (39.6) | 37 (17.1) |
History of infertility | 23 (10.6) | 30 (13.8) | 81 (37.3) | 56 (25.8) | 27 (12.4) |
Nulliparity | 48 (22.3) | 42 (19.5) | 88 (40.9) | 25 (11.6) | 12 (5.6) |
Multiparity | 1 (0.5) | 7 (3.3) | 58 (27.0) | 105 (48.8) | 44 (20.5) |
FH ovarian cancer | 171 (75.7) | 37 (16.4) | 18 (8.0) | 0 | 0 |
PH breast cancer | 110 (49.3) | 66 (29.6) | 42 (18.8) | 3 (1.3) | 2 (0.9) |
FH breast cancer | 83 (37.9) | 66 (30.1) | 58 (26.5) | 10 (4.6) | 2 (0.9) |
Obesity (BMI>40) | 57 (25.8) | 80 (36.2) | 66 (29.9) | 13 (5.9) | 5 (2.3) |
HRT use | 17 (7.7) | 31 (14.1) | 86 (39.1) | 59 (26.8) | 27 (12.3) |
Previous hormonal contraception | 5 (2.3) | 19 (8.6) | 48 (21.7) | 97 (43.9) | 52 (23.5) |
No previous hormonal contraception | 18 (8.2) | 25 (11.4) | 84 (38.2) | 56 (25.5) | 37 (16.8) |